期刊文献+

Is the advantage of coronary bypass graft surgery over percutaneous coronary intervention in diabetic patients with severe multivessel disease influenced by the status of insulin requirement? 被引量:1

Is the advantage of coronary bypass graft surgery over percutaneous coronary intervention in diabetic patients with severe multivessel disease influenced by the status of insulin requirement?
下载PDF
导出
摘要 几研究证明了冠的动脉绕过接枝外科(CABG ) 在有糖尿病和多容器疾病的病人比经皮的冠的干预(一种总线标准) 优异。在一种总线标准上的 CABG 的这个优点是否被限制到要求胰岛素的糖尿病患者,是未知的。我们考察包括 8 个队和 4,786 个病人在糖尿病患者把 CABG 与一种总线标准作比较的出版文学。为所有原因死亡有更低的率(相对风险(RR ) :0.78, 95% 信心间隔(CI ) :0.62-0.99 ) ,并且为主要不利心脏、脑血管的事件(MACCE, RR:0.59, 95% CI:0.47-0.75 ) 为与一种总线标准相比的 CABG。死亡的合成结果,心肌的梗塞并且司烧在 CABG 和一种总线标准之间是类似的(RR:0.87, 95% CI:0.54-1.42 ) 。森林阴谋的视觉检查证明在大多数分析, RR 的点估计在要求组和非胰岛素要求组的胰岛素之间是类似的。在元回归上,在胰岛素要求和 revascularization 策略的地位之间没有相互作用(P >0.05 为所有) 。FREEDOM 试用的仍然未出版的分析上的介绍数据显示出类似的结果。因此在当前的时代, CABG 比有更低的死亡和 MACCE 率的一种总线标准优异,但是胰岛素要求的状态没从二 revascularization 策略在结果上有效果。 Several studies have shown that coronary artery bypass graft surgery (CABG) is superior to percutaneous coronary intervention (PCI) in patients with diabetes and multi-vessel disease. Whether this advantage of CABG over PCI is confined to diabetics who require insulin is unknown. We review the published literature comparing CABG with PCI in diabetics including 8 cohorts and 4,786 patients. There was a lower rate for all-cause mortality (Relative risk (RR): 0.78, 95% confidence interval (CI): 0.62-0.99), and for major adverse cardiac and cerebrovascular events (MACCE, RR: 0.59, 95% CI: 0.47-0.75) for CABG compared to PCI. Composite outcome of mortality, myocardial infarction and stoke was similar between CABG and PCI (RR: 0.87, 95% CI: 0.54-1.42). Visual inspection of the forest plots showed that in most analyses, the point estimates of the RR are similar between the insulin requiring group and non-insulin requiring group. On meta-regression, there was no interaction between status of insulin requirement and revascularization strategies (P 〉 0.05 for all). The pre- sented data on the still unpublished analysis of the FREEDOM trial showed similar results. Thus, in the current era, CABG is superior to PCI with lower mortality and MACCE rates, but the state of insulin requirement had no effect on the outcomes from the two revascularization strategies.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2014年第1期83-89,共7页 老年心脏病学杂志(英文版)
关键词 冠状动脉 介入治疗 血管病变 胰岛素 糖尿病 患者 状态 优势 Percutaneous coronary intervention Coronary artery bypass graft surgery Diabetes mellims Insulin Multivessel disease
  • 相关文献

参考文献29

  • 1Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998; 21(Suppl 3): C11-C14.
  • 2Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-2038.
  • 3Brooks MM, Jones RH, Bach RG, et al. Predictors of mortal- ity and mortality from cardiac causes in the bypass angio- plasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation 2000; 101: 2682-2689.
  • 4Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Com- parative effectiveness of revascularization strategies. N Engl J Med2012; 366:1467 1476.
  • 5Nicholls S J, Tuzcu EM, Kalidindi S, et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remod- eling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardio12008; 52: 255-262.
  • 6Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revasculariza- tion Investigation (BARI). Circulation 1997; 96:1761-1769.
  • 7King SB III, Kosinski AS, Guyton RA, et al. Eight-year mor- tality in the Emory Angioplasty versus Surgery Trial (EAST). JAm Coll Cardio12000; 35:1116 -1121.
  • 8Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arte- rial Revascularization Therapies Study (ARTS) randomized trial. JAm Coll Cardio12005; 46:575-5 81.
  • 9Rodriguez AE, Baldi J, Fem~dez Pereira C, et al. Five-year follow-up of the Argentine randomized trial of coronary an- gioplasty with stenting versus coronary bypass surgery in pa- tients with multiple vessel disease (ERACI II). J Am Coll Cardio12005; 46:582 588.
  • 10Hueb W, Lopes NH, Gersh B J, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 1082-1089.

同被引文献21

  • 1Brenes-Salazar JA, Forman DE. Advances in percutaneous cor- onary interventions for elderly patients [J]. Progress in Cardio- vascular Diseases, 2014,57 (2): 176-186.
  • 2Bauer T, Mollmann H, Weidinger F, et al. Predictors of hospital mortality m the elderly undergoing percutaneous coron- ary intervention for acute coronary syndromes and stable angina [J]. International Journal of Cardiology, 2011,151 (2): 164 -169.
  • 3Antman EM, Anbe DT, Armstrong PW, eta1. 2004ACC/AHA guidelines for the management of patients with ST-elevation my- ocardial infarction executive summary. A report of the American college of cardiology/American heart association task force on- practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) [J]. Criculation, 2004,110 (9): e82-292.
  • 4Karha J, Topoi EJ. Primary percutaneous coronary intervention vs. fibrinolytic therapy for acute ST-elevation, yocardial m- fraction in the elderly [J]. Am J Geriatr Cardiol, 2006,15: 19-21.
  • 5Stenestrand. Ulf, Lars W. Fibrinolytic therapy in patients 75 years and older with ST-segment elevation myocardial infarction [J]. Arch lnternMed, 2003,163 (8): 965-971.
  • 6Mehta RH, Granger CB, et al. Reperfusion strategies for acute myocardial infarction in the elderly: Benefits and Risks [J]. American College of Cardiology, 2005,45 (4): 471-478.
  • 7Ayanian JZ, Braunwald E. Thrombolytic therapy for patients with myocardial in farction who are older than 75 years: do the risks outweigh the benefits [J]. Circulation, 2000,101:2224-2226.
  • 8Fibrinolytic therapy trialists' (FTT) Collaborative Group. Indi- cations for fibrinolytic therapy in suspected acute myocardial in- farction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients [J]. Lancet, 1994,343 : 311-322.
  • 9Bueno H, Betriu A, Heras M, et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN An- cianos) randomized trial and pooled analysis with previous stu- dies. [J]. European Heart Journal, 2011,32 : 51-60.
  • 10Dalby M, Bouzamondo A, Lechat P, etal. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infraction a meta-analysis [J]. Circulation, 2003,108 (15): 1809-1814.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部